Search research articles
Contact Us
Filters
Showing results (1-10 of 241) with videos related to
Page
of 25
Sort By:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
November 1, 1993
Orally administered interferons suppress bone marrow function
S Koren, W R Fleischmann
Journal of Interferon Research
|
October 1, 1986
Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice
S Koren, W R Fleischmann
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
September 7, 1999
Systemic effects of orally administered interferons and interleukin-2
W R Fleischmann, S Koren
Journal of Interferon Research
|
June 1, 1993
Optimal circadian timing reduces the myelosuppressive activity of recombinant murine interferon-gamma administered to mice
S Koren, W R Fleischmann
Journal of Interferon Research
|
December 1, 1994
Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2
S Koren, W R Fleischmann
Experimental Hematology
|
April 1, 1993
Circadian variations in myelosuppressive activity of interferon-alpha in mice: identification of an optimal treatment time associated with reduced myelosuppressive activity
S Koren, W R Fleischmann
Journal of Biological Response Modifiers
|
October 1, 1986
Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons
S Koren, G R Klimpel, W R Fleischmann
Journal of the National Cancer Institute
|
December 1, 1993
Circadian dependence of interferon antitumor activity in mice
S Koren, E B Whorton, W R Fleischmann
Journal of Biological Response Modifiers
|
December 1, 1986
Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro
S Koren, G R Klimpel, W R Fleischmann
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
November 11, 1992
Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism
W R Fleischmann, S Koren, C M Fleischmann
Page
of 25
Search research articles
Search
Showing results (1-10 of 241) with videos related to
Sort By:
Page
of 25
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
November 1, 1993
Orally administered interferons suppress bone marrow function
S Koren, W R Fleischmann
Journal of Interferon Research
|
October 1, 1986
Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice
S Koren, W R Fleischmann
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
September 7, 1999
Systemic effects of orally administered interferons and interleukin-2
W R Fleischmann, S Koren
Journal of Interferon Research
|
June 1, 1993
Optimal circadian timing reduces the myelosuppressive activity of recombinant murine interferon-gamma administered to mice
S Koren, W R Fleischmann
Journal of Interferon Research
|
December 1, 1994
Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2
S Koren, W R Fleischmann
Experimental Hematology
|
April 1, 1993
Circadian variations in myelosuppressive activity of interferon-alpha in mice: identification of an optimal treatment time associated with reduced myelosuppressive activity
S Koren, W R Fleischmann
Journal of Biological Response Modifiers
|
October 1, 1986
Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons
S Koren, G R Klimpel, W R Fleischmann
Journal of the National Cancer Institute
|
December 1, 1993
Circadian dependence of interferon antitumor activity in mice
S Koren, E B Whorton, W R Fleischmann
Journal of Biological Response Modifiers
|
December 1, 1986
Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro
S Koren, G R Klimpel, W R Fleischmann
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
November 11, 1992
Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism
W R Fleischmann, S Koren, C M Fleischmann
Page
of 25